TO ALL ENLISTED: tMDS/AML CANCER RISK ELEVATED IN CHEMOTHERAPY PATIENTS WITH SOLID TUMORS:

https://www.cancer.gov/news-events/press-releases/2018/tMDS-AML-risk-chemo

https://jamanetwork.com/journals/jamaoncology/article-abstract/2718413

https://www.ajmc.com/newsroom/chemotherapy-for-solid-tumors-associated-with-increased-risk-of-aml-mds

https://www.medpagetoday.com/hematologyoncology/leukemia/77117

http://www.bloodjournal.org/content/100/2/427.reprint%3Fsso-checked%3D1&ved=2ahUKEwiAlqqCw8TfAhVo44MKHc91Bd4QFjAHegQIChAB&usg=AOvVaw3KmShxW1OXf-FaGFa2-Lql

http://www.bloodjournal.org/content/116/21/2911?sso-checked=true

http://cancerres.aacrjournals.org/content/77/13_Supplement/LB-236

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269479/

https://www.ncbi.nlm.nih.gov/pubmed/29236346

https://www.oncnet.com/news/excess-risk-secondary-mds-aml-found-recipients-chemo-solid-tumors

PANCREATIC CANCER:

https://www.pancan.org/news/new-cancer-drug-approved-based-on-molecular-profiling/

CHLAMYDIA AND OVARIAN CANCER:

https://www.nbcnews.com/health/health-news/chlamydia-doubled-ovarian-cancer-risk-study-shows-n856986